Sparkling cannabis-infused water in cans gets US debut

Sparkling water with extracts from cannabis plants is to be sold in cans through 7-Eleven convenience stores in the US.
Day One CBD Sparkling Water in cans will be the first product launched by Natural Hemp Co, a US producer of cannabidiol (CBD).

The drink, in 12oz cans, will initially be available in a lemon variant in the US before new flavours are introduced later this year, according to press reports.

It will be sold across the US in selected outlets, including 7-Eleven convenience stores and natural food stores. 

“Day One is a perfectly balanced sparkling water that is infused with 20mg of broad-spectrum CBD with a splash of lemon fruit juice,” FoodBev Media reported Chris Clifford, chief executive of Natural Hemp Company as saying.

“We only use all-natural ingredients and our waters have zero calories, zero carbs and no added sweeteners.”

Natural Hemp Company reportedly said that while CBD is effective in inhalable and edible forms, CBD-infused water is much easier for the body to absorb, making for a more effective, hydrating, and faster-acting experience.

The company highlighted the potential health benefits of CBD, including increased energy levels, pain relief, improved focus, and anxiety relief.

The new products contain 20mg of ‘broad-spectrum’ CBD extracted from hemp, giving a reported 80 per cent bioavailability.

Last July, The Canmaker reported that Lagunitas Brewing had launched a cannabis-infused sparkling beverage in cans in order to take advantage of the burgeoning cannabis market in California. Named Hi-Fi Hops, it was only available at licensed cannabis dispensaries.

It came in two varieties, including one containing 10mg of tetrahydrocannabinol (THC), a principal psychoactive chemical in marijuana. The other had 5mg of THC and 5mg of CBD, which is also sometimes used to treat pain.

Regulatory uncertainty from the US Food and Drug Administration (FDA) about the future of cannabis and CBD-infused products has deterred other brand owners from entering this market. An update on the FDA position on CBD use is expected in the autumn.